Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis

Nature Medicine

Volumn 11, Issue 3, 2005, Pages 328-334

  Greter, Melanie ^a   Heppner, Frank L ^b   Lemos, Maria P ^c   Odermatt, Bernhard M ^d   Goebels, Norbert ^a   Laufer, Terri ^c   Noelle, Randolph J ^e   Becher, Burkhard ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLT3 LIGAND; IMMUNOGLOBULIN G; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN;

ADOPTIVE TRANSFER; ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; CELL TYPE; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DENDRITIC CELL; DISEASE SEVERITY; ENZYME LINKED IMMUNOSPOT ASSAY; FLOW CYTOMETRY; HELPER CELL; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE MIGRATION; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; RETICULOENDOTHELIAL SYSTEM; SPLENECTOMY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD11C; BRAIN; CELL MOVEMENT; CHIMERA; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GENES, MHC CLASS II; HUMANS; MICE; MULTIPLE SCLEROSIS; MYELIN SHEATH; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 16244380177     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm1197     Document Type: Article

References (40)

1. Steinman, L. Multiple sclerosis: a coordinated immunological attack against myelin in the central nervous system. Cell 85, 299-302 (1996).
2. Krummel, M.F. & Davis, M.M. Dynamics of the immunological synapse: finding, establishing and solidifying a connection. Curr. Opin. Immunol. 14, 66-74 (2002).
3. Slavin, A.J. et al. Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity. J. Clin. Invest 108, 1133-1139 (2001).
4. Lee, S.C. & Raine, C.S. Multiple sclerosis: oligodendrocytes in active lesions do not express class II major histocompatibility complex molecules. J. Neuroimmunol. 25, 261-266 (1989).
5. Wong, G.H., Bartlett, P.F., Clark-Lewis, I., Battye, F., & Schrader, J.W. Inducible expression of H-2 and la antigens on brain cells. Nature 310, 688-691 (1984).
6. Becher, B., Prat, A., & Antel, J.P. Brain-immune connection: immuno-regulator properties of CNS-resident cells. Glia 29, 293-304 (2000).
7. Fierz, W., Endler, B., Reske, K., Wekerle, H., & Fontana, A. Astrocytes as antigen-presenting cells. I. Induction of la antigen expression on astrocytes by T cells via immune interferon and its effect on antigen presentation. J. Immunol. 134, 3785-3793 (1985).
8. Ford, A.L., Foulcher, E., Lemckert, F.A., & Sedgwick, J.D. Microglia induce CD4 T lymphocyte final effector function and death. J. Exp. Med. 184, 1737-1745 (1996).
9. Ford, A.L., Goodsall, A.L. Mickey, W.F., & Sedgwick, J.D. Normal adult ramified microglia separated from other central nervous system macrophages by flow cytometric sorting. Phenotypic differences defined and direct ex vivo antigen presentation to myelin basic protein-reactive CD4+ T cells compared. J. Immunol. 154, 4309-4321 (1995).
10. Carson, M.J., Reilly, C.R., Sutcliffe, J.G., & Lo, D. Mature microglia resemble immature antigen presenting cells. Glia 22, 72-85 (1998).
11. Flugel, A. et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. Immunity 14, 547-560 (2001).
12. Hickey, W.F. Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation. Brain Pathol. 1, 97-105 (1991).
13. Shinkura, R. et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-kappa b-inducing kinase. Nat. Genet. 22, 74-77 (1999).
14. Hickey, W.F. & Kimura, H. Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo. Science 239, 290-292 (1988).
15. Becher, B. & Antel, J.P. Comparison of phenotypic and functional properties of immediately ex vivo and cultured human adult microglia. Glia 18, 1-10 (1996).
16. Matyszak, M.K. et al. Microglia induce myelin basic protein-specific T cell anergy or T cell activation, according to their state of activation. Eur. J. Immunol. 29, 3063-3076 (1999).
17. Ulvestad, E. et al. Human microglial cells have phenotypic and functional characteristics in common with both macrophages and dendritic antigen-presenting cells. J. Leukoc. Biol. 56, 732-740 (1994).
18. Becher, B., Durell, B.G., Miga, A.V., Hickey, W.F., & Noelle, R.J. The clinical course of experimental autoimmune encephalomyelitis and inflammation is controlled by the expression of CD40 within the central nervous system. J. Exp. Med. 193, 967-974 (2001).
19. Becher, B., Durell, B.G., & Noelle, R.J. IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest 112, 1186-1191 (2003).
20. Hickey, W.F., Vass, K., & Lassmann, H. Bone marrow-derived elements in the central nervous system: an immunohistochemical and ultrastructural survey of rat chimeras. J. Neuropathol. Exp. Neurol. 51, 246-256 (1992).
21. Asheuer, M. et al. Human CD34+ cells differentiate into microglia and express recombinant therapeutic protein. Proc. Natl. Acad. Sci. USA 101, 3557-3562 (2004).
22. Lassmann, H., Schmied, M., Vass, K., & Hickey, W.F. Bone marrow derived elements and resident microglia in brain inflammation. Glia 7, 19-24 (1993).
23. Kivisakk, P. et al. Expression of CCR7 in multiple sclerosis: implications for CNS immunity. Ann. Neurol. 55, 627-638 (2004).
24. McMenamin, P.G. Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations. J. Comp Neurol. 405, 553-562 (1999).
25. Matyszak, M.K. & Perry, V.H. The potential role of dendritic cells in immune-mediated inflammatory diseases in the central nervous system. Neurosci. 74, 599-608 (1996).
26. Serafini, B., Columba-Cabezas, S., Di Rosa, F., & Aloisi, F. Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis. Am. J. Pathol. 157, 1991-2002 (2000).
27. Lemos, M.P., Esquivel, F., Scott, P., & Laufer, T.M. MHC class II expression restricted to CD8{alpha}+ and CD11b+ dendritic cells is sufficient for control of Leishmania major. J. Exp. Med. 199, 725-730 (2004).
28. Lemos, M.P., Fan, L., Lo, D., & Laufer, T.M. CD8alpha+ and CD11b+ dendritic cell-restricted MHC class II controls Th1 CD4+ T cell immunity. J. Immunol. 171, 5077-5084 (2003).
29. Geijtenbeek, T.B, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100, 575-585 (2000).
30. O'Keeffe, M. et al. Effects of administration of progenipoietin 1, Flt-3 ligand, granulocyte colony-stimulating factor, and pegylated granulocyte-macrophage colony-stimulating factor on dendritic cell subsets in mice. Blood 99, 2122-2130 (2002).
31. Maraskovsky, E. et al. Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice; multiple dendritic cell subpopulations identified. J. Exp. Med. 184, 1953-1962 (1996).
32. Stuve, O. et al. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J. Immunol. 169, 6720-6732 (2002).
33. Mossner, R. et al. Astrocytes as antigen presenting cells for primary and secondary T cell responses: effect of astrocyte infection by murine hepatitis virus. Adv. Exp. Med. Biol. 276, 647-654 (1990).
34. Aloisi, F., Ria, F., Penna, G., & Adorini, L. Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 cell activation. J. Immunol. 160, 4671-4680 (1998).
35. Juedes, A.E. & Ruddle, N.H. Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis. J. Immunol. 166, 5168-5175 (2001).
36. Cua, D.J. et al. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748 (2003).
37. Heppner, F.L. et al. Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat. Med. 11, 146-152 (2005).
38. Raine, C.S., Mokhtarian, F., & McFarlin, D.E. Adoptively transferred chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Neuropathologic analysis. Lab Invest 51, 534-546 (1984).
39. Prineas, J.W. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 203, 1123-1125 (1979).
40. McMahon, E.J. et al. Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. Nat. Med. 11, 335-339 (2005).